The role of TGF-beta3 in cartilage development and osteoarthritis

Abstract

Articular cartilage serves as a low-friction, load-bearing tissue without the support with blood vessels, lymphatics and nerves, making its repair a big challenge. Transforming growth factor-beta 3 (TGF-β3), a vital member of the highly conserved TGF-β superfamily, plays a versatile role in cartilage physiology and pathology. TGF-β3 influences the whole life cycle of chondrocytes and mediates a series of cellular responses, including cell survival, proliferation, migration, and differentiation. Since TGF-β3 is involved in maintaining the balance between chondrogenic differentiation and chondrocyte hypertrophy, its regulatory role is especially important to cartilage development. Increased TGF-β3 plays a dual role: in healthy tissues, it can facilitate chondrocyte viability, but in osteoarthritic chondrocytes, it can accelerate the progression of disease. Recently, TGF-β3 has been recognized as a potential therapeutic target for osteoarthritis (OA) owing to its protective effect, which it confers by enhancing the recruitment of autologous mesenchymal stem cells (MSCs) to damaged cartilage. However, the biological mechanism of TGF-β3 action in cartilage development and OA is not well understood. In this review, we systematically summarize recent progress in the research on TGF-β3 in cartilage physiology and pathology, providing up-to-date strategies for cartilage repair and preventive treatment.

References

[1] Lafyatis R. Transforming growth factor β–at the centre of systemic sclerosis. Nat. Rev. Rheumatol., 2014, 10: 706-719

[2] Pickup M, Novitskiy S, Moses HL. The roles of TGFβ in the tumour microenvironment. Nat. Rev. Cancer, 2013, 13: 788-799

[3] Occleston NL, Laverty HG, O’Kane S, Ferguson MWJ. Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGF beta 3): from laboratory discovery to clinical pharmaceutical. J. Biomater. Sci. Polym. Ed., 2008, 19: 1047-1063

[4] Moses HL, Roberts AB, Derynck R. The discovery and early days of TGF-beta: a historical perspective. Cold Spring Harb. Perspect. Biol., 2016, 8: a021865

[5] Grimaud E, Heymann D, Redini F. Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. Cytokine Growth Factor Rev., 2002, 13: 241-257

[6] Moutos FT, Freed LE, Guilak F. A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nat. Mater., 2007, 6: 162-167

[7] Shoulders MD, Raines RT. Collagen structure and stability. Annu. Rev. Biochem., 2009, 78: 929-958

[8] Kiani C, Chen L, Wu YJ, Yee AJ, Yang BB. Structure and function of aggrecan. Cell Res., 2002, 12: 19-32

[9] Cai L et al. Biomaterial stiffness guides cross-talk between chondrocytes: implications for a novel cellular response in cartilage tissue engineering. ACS Biomater. Sci. Eng., 2020, 6: 4476-4489

[10] Wei J et al. Osteoblasts induce glucose-derived ATP perturbations in chondrocytes through noncontact communication. Acta Biochim. Biophys. Sin. (Shanghai)., 2022, 54: 625-636

[11] Hootman JM, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum., 2006, 54: 226-229

[12] Xie J, Zhang D, Lin Y, Yuan Q, Zhou X. Anterior cruciate ligament transection-induced cellular and extracellular events in menisci: implications for osteoarthritis. Am. J. Sports Med., 2018, 46: 1185-1198

[13] Yoo KH et al. Transforming growth factor-beta family and stem cell-derived exosome therapeutic treatment in osteoarthritis (Review). Int. J. Mol. Med., 2022, 49: 62

[14] Wang MK et al. Different roles of TGF-beta in the multi-lineage differentiation of stem cells. World J. Stem Cells, 2012, 4: 28-34

[15] Wrana JL, Attisano L. The Smad pathway. Cytokine Growth Factor Rev., 2000, 11: 5-13

[16] Thielen NGM, van der Kraan PM, van Caam APM. TGFbeta/BMP signaling pathway in cartilage homeostasis. Cells, 2019, 8: 969

[17] Jin K et al. TGF-β1-induced RAP2 regulates invasion in pancreatic cancer. Acta Biochim. Biophys. Sin. (Shanghai)., 2022, 54: 361-369

[18] de Larco JE, Todaro GJ. Growth factors from murine sarcoma virus-transformed cells. Proc. Natl Acad. Sci. USA, 1978, 75: 4001-4005

[19] Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc. Natl Acad. Sci. USA, 1981, 78: 5339-5343

[20] Anzano MA et al. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res., 1982, 42: 4776-4778

[21] Herpin A, Lelong C, Favrel P. Transforming growth factor-beta-related proteins: an ancestral and widespread superfamily of cytokines in metazoans. Dev. Comp. Immunol., 2004, 28: 461-485

[22] Okamura T, Yamamoto K, Fujio K. Early growth response gene 2-expressing CD4(+)LAG3(+) regulatory T cells: the therapeutic potential for treating autoimmune diseases. Front. Immunol., 2018, 9: 340

[23] Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J. Cell Sci., 2003, 116: 217-224

[24] Okamura T et al. Role of TGF-beta3 in the regulation of immune responses. Clin. Exp. Rheumatol., 2015, 33: S63-S69

[25] Chaudhry SS et al. Fibrillin-1 regulates the bioavailability of TGFbeta1. J. Cell Biol., 2007, 176: 355-367

[26] Ge G, Greenspan DS. BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. J. Cell Biol., 2006, 175: 111-120

[27] Sengle G, Ono RN, Sasaki T, Sakai LY. Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability. J. Biol. Chem., 2011, 286: 5087-5099

[28] Koli K, Myllarniemi M, Keski-Oja J, Kinnula VL. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid. Redox Signal., 2008, 10: 333-342

[29] Shi M et al. Latent TGF-beta structure and activation. Nature, 2011, 474: 343-349

[30] Annes JP, Chen Y, Munger JS, Rifkin DB. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J. Cell Biol., 2004, 165: 723-734

[31] Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Eur. J. Cell Biol., 2008, 87: 601-615

[32] Wang J et al. Atypical interactions of integrin alphaVbeta8 with pro-TGF-beta1. Proc. Natl. Acad. Sci. USA, 2017, 114: E4168-E4174

[33] Annes JP, Rifkin DB, Munger JS. The integrin alphaVbeta6 binds and activates latent TGFbeta3. FEBS Lett., 2002, 511: 65-68

[34] Cordeiro MF. Beyond Mitomycin: TGF-beta and wound healing. Prog. Retin. Eye Res., 2002, 21: 75-89

[35] Yoshinaga K et al. Perturbation of transforming growth factor (TGF)-beta1 association with latent TGF-beta binding protein yields inflammation and tumors. Proc. Natl. Acad. Sci. USA, 2008, 105: 18758-18763

[36] Robertson IB et al. Latent TGF-beta-binding proteins. Matrix Biol., 2015, 47: 44-53

[37] Saharinen J, Keski-Oja J. Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta. Mol. Biol. Cell, 2000, 11: 2691-2704

[38] Rifkin DB, Rifkin WJ, Zilberberg L. LTBPs in biology and medicine: LTBP diseases. Matrix Biol., 2018, 71-72: 90-99

[39] Zuo W et al. c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-beta type II receptor. Mol. Cell, 2013, 49: 499-510

[40] Atfi A et al. The disintegrin and metalloproteinase ADAM12 contributes to TGF-beta signaling through interaction with the type II receptor. J. Cell Biol., 2007, 178: 201-208

[41] Kang JS, Liu C, Derynck R. New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol., 2009, 19: 385-394

[42] Imamura T, Oshima Y, Hikita A. Regulation of TGF-beta family signalling by ubiquitination and deubiquitination. J. Biochem., 2013, 154: 481-489

[43] Hinck AP. Structural studies of the TGF-betas and their receptors - insights into evolution of the TGF-beta superfamily. FEBS Lett., 2012, 586: 1860-1870

[44] Goumans MJ, Liu Z, ten Dijke P. TGF-beta signaling in vascular biology and dysfunction. Cell Res., 2009, 19: 116-127

[45] Mitchell EJ, Fitz-Gibbon L, O’Connor-McCourt MD. Subtypes of betaglycan and of type I and type II transforming growth factor-beta (TGF-beta) receptors with different affinities for TGF-beta 1 and TGF-beta 2 are exhibited by human placental trophoblast cells. J. Cell. Physiol., 1992, 150: 334-343

[46] Huang T et al. TGF-beta signalling is mediated by two autonomously functioning TbetaRI:TbetaRII pairs. EMBO J., 2011, 30: 1263-1276

[47] Tzavlaki K, Moustakas A. TGF-beta signaling. Biomolecules, 2020, 10: 487

[48] Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature, 2003, 425: 577-584

[49] Feng XH, Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu. Rev. Cell Dev. Biol., 2005, 21: 659-693

[50] Gaarenstroom T, Hill CS. TGF-beta signaling to chromatin: how Smads regulate transcription during self-renewal and differentiation. Semin. Cell Dev. Biol., 2014, 32: 107-118

[51] Makkar P, Metpally RP, Sangadala S, Reddy BV. Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif. J. Mol. Graph. Model., 2009, 27: 803-812

[52] MacFarlane EG, Haupt J, Dietz HC, Shore EM. TGF-beta family signaling in connective tissue and skeletal diseases. Cold Spring Harb. Perspect. Biol., 2017, 9: a022269

[53] Derynck R, Budi EH. Specificity, versatility, and control of TGF-beta family signaling. Sci. Signal., 2019, 12: eaav5183

[54] Yano M et al. Smad7 inhibits differentiation and mineralization of mouse osteoblastic cells. Endocr. J., 2012, 59: 653-662

[55] Inman GJ. Linking Smads and transcriptional activation. Biochem. J., 2005, 386: e1-e3

[56] Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H. Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J. Biol. Chem., 2005, 280: 8343-8350

[57] Inman GJ, Nicolas FJ, Hill CS. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol. Cell, 2002, 10: 283-294

[58] Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev., 2005, 19: 2783-2810

[59] Hill CS. Transcriptional control by the SMADs. Cold Spring Harb. Perspect. Biol., 2016, 8: a022079

[60] Lee MK et al. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J., 2007, 26: 3957-3967

[61] Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 2002, 298: 1911-1912

[62] Yamashita M et al. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol. Cell, 2008, 31: 918-924

[63] Tang QO et al. TGF-beta3: A potential biological therapy for enhancing chondrogenesis. Expert Opin. Biol. Ther., 2009, 9: 689-701

[64] Wang Q et al. The involvement of the ERK-MAPK pathway in TGF-β1-mediated connexin43-gap junction formation in chondrocytes. Connect. Tissue Res., 2019, 60: 477-486

[65] Yang Y et al. Lipid metabolism in cartilage and its diseases: a concise review of the research progress. Acta Biochim. Biophys. Sin. (Shanghai)., 2021, 53: 517-527

[66] Tew SR, Hardingham TE. Regulation of SOX9 mRNA in human articular chondrocytes involving p38 MAPK activation and mRNA stabilization. J. Biol. Chem., 2006, 281: 39471-39479

[67] Kim SJ et al. ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status. J. Biol. Chem., 2002, 277: 1332-1339

[68] Yoon YM et al. Maintenance of differentiated phenotype of articular chondrocytes by protein kinase C and extracellular signal-regulated protein kinase. J. Biol. Chem., 2002, 277: 8412-8420

[69] Rosenzweig DH, Ou SJ, Quinn TM. P38 mitogen-activated protein kinase promotes dedifferentiation of primary articular chondrocytes in monolayer culture. J. Cell. Mol. Med., 2013, 17: 508-517

[70] Hirose N et al. Protective effects of cilengitide on inflammation in chondrocytes under excessive mechanical stress. Cell Biol. Int., 2020, 44: 966-974

[71] Qiao B, Padilla SR, Benya PD. Transforming growth factor (TGF)-beta-activated kinase 1 mimics and mediates TGF-beta-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling. J. Biol. Chem., 2005, 280: 17562-17571

[72] Gunnell LM et al. TAK1 regulates cartilage and joint development via the MAPK and BMP signaling pathways. J. Bone Miner. Res., 2010, 25: 1784-1797

[73] Shim JH et al. TAK1 is an essential regulator of BMP signalling in cartilage. EMBO J., 2009, 28: 2028-2041

[74] Wang Q et al. TGF-β1 promotes gap junctions formation in chondrocytes via Smad3/Smad4 signalling. Cell Prolif., 2019, 52: e12544

[75] Zhang Y et al. Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis. Ann. Rheum. Dis., 2015, 74: 1432-1440

[76] Liu Y et al. PDGF-AA promotes cell-to-cell communication in osteocytes through PI3K/Akt signaling pathway. Acta Biochim. Biophys. Sin. (Shanghai)., 2021, 53: 1640-1649

[77] Woods A, Wang G, Beier F. RhoA/ROCK signaling regulates Sox9 expression and actin organization during chondrogenesis. J. Biol. Chem., 2005, 280: 11626-11634

[78] Woods A, Beier F. RhoA/ROCK signaling regulates chondrogenesis in a context-dependent manner. J. Biol. Chem., 2006, 281: 13134-13140

[79] Haudenschild DR, Chen J, Pang N, Lotz MK, D’Lima DD. Rho kinase-dependent activation of SOX9 in chondrocytes. Arthritis Rheum., 2010, 62: 191-200

[80] Javelaud D, Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene, 2005, 24: 5742-5750

[81] Hu B et al. TGF-beta induces up-regulation of chondroitin sulfate synthase 1 (CHSY1) in nucleus pulposus cells through MAPK signaling. Cell. Physiol. Biochem., 2015, 37: 793-804

[82] Ratti M et al. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside. Target. Oncol., 2020, 15: 261-278

[83] Zhang M et al. miR-199b-5p promoted chondrogenic differentiation of C3H10T1/2 cells by regulating JAG1. J. Tissue Eng. Regen. Med., 2020, 14: 1618-1629

[84] Zhang Y, Huang X, Yuan Y. MicroRNA-410 promotes chondrogenic differentiation of human bone marrow mesenchymal stem cells through down-regulating Wnt3a. Am. J. Transl. Res., 2017, 9: 136-145

[85] Lee S et al. microRNA-495 inhibits chondrogenic differentiation in human mesenchymal stem cells by targeting Sox9. Stem Cells Dev., 2014, 23: 1798-1808

[86] Zhou C et al. Runx1 protects against the pathological progression of osteoarthritis. Bone Res., 2021, 9: 50

[87] Duan M, Wang Q, Liu Y, Xie J. The role of TGF-β2 in cartilage development and diseases. Bone Jt. Res., 2021, 10: 474-487

[88] Majd SE et al. Both hyaluronan and collagen type II keep proteoglycan 4 (lubricin) at the cartilage surface in a condition that provides low friction during boundary lubrication. Langmuir, 2014, 30: 14566-14572

[89] Rhee DK et al. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J. Clin. Investig., 2005, 115: 622-631

[90] Chen H, Li J, Zhang D, Zhou X, Xie J. Role of the fibroblast growth factor 19 in the skeletal system. Life Sci., 2021, 265: 118804

[91] van der Kraan PM, van den Berg WB. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthr. Cartil., 2012, 20: 223-232

[92] Li J, Chen H, Zhang D, Xie J, Zhou X. The role of stromal cell-derived factor 1 on cartilage development and disease. Osteoarthr. Cartil., 2021, 29: 313-322

[93] Melrose J, Smith SM, Smith MM, Little CB. The use of Histochoice for histological examination of articular and growth plate cartilages, intervertebral disc and meniscus. Biotech. Histochem., 2008, 83: 47-53

[94] Burdan F et al. Morphology and physiology of the epiphyseal growth plate. Folia Histochem. Cytobiol., 2009, 47: 5-16

[95] Michigami T. Regulatory mechanisms for the development of growth plate cartilage. Cell. Mol. Life Sci., 2013, 70: 4213-4221

[96] Kronenberg HM. Developmental regulation of the growth plate. Nature, 2003, 423: 332-336

[97] Siebler T, Shalet SM, Robson H. Effects of chemotherapy on bone metabolism and skeletal growth. Horm. Res., 2002, 58: 80-85

[98] Shum L, Nuckolls G. The life cycle of chondrocytes in the developing skeleton. Arthritis Res., 2002, 4: 94-106

[99] Horner A et al. Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Bone, 1998, 23: 95-102

[100] Baardsnes J, Hinck CS, Hinck AP, O’Connor-McCourt MD. TbetaR-II discriminates the high- and low-affinity TGF-beta isoforms via two hydrogen-bonded ion pairs. Biochemistry, 2009, 48: 2146-2155

[101] Sefat F, Youseffi M, Khaghani SA, Soon CF, Javid F. Effect of transforming growth factor-beta3 on mono and multilayer chondrocytes. Cytokine, 2016, 83: 118-126

[102] Jin EJ, Choi YA, Sonn JK, Kang SS. Suppression of ADAM 10-induced Delta-1 shedding inhibits cell proliferation during the chondro-inhibitory action of TGF-beta3. Mol. Cells, 2007, 24: 139-147

[103] Martinez-Alvernia EA, Rudnick JA, Mankarious LA. Transforming growth factor beta3 increases chondrocyte proliferation and decreases apoptosis in murine cricoid cartilage in vitro. Otolaryngol. Head. Neck Surg., 2008, 138: 435-440

[104] James AW, Xu Y, Lee JK, Wang R, Longaker MT. Differential effects of TGF-beta1 and TGF-beta3 on chondrogenesis in posterofrontal cranial suture-derived mesenchymal cells in vitro. Plast. Reconstr. Surg., 2009, 123: 31-43

[105] Ma XF et al. Co-culture of adipose-derived stem cells and chondrocytes with transforming growth factor-beta 3 promotes chondrogenic differentiation. J. Craniofac. Surg., 2020, 31: 2355-2359

[106] Makhijani NS, Bischoff DS, Yamaguchi DT. Regulation of proliferation and migration in retinoic acid treated C3H10T1/2 cells by TGF-beta isoforms. J. Cell. Physiol., 2005, 202: 304-313

[107] Gao J et al. Characterization of OP9 as authentic mesenchymal stem cell line. J. Genet. Genom., 2010, 37: 475-482

[108] Lee CH et al. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet, 2010, 376: 440-448

[109] Brittberg M et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med., 1994, 331: 889-895

[110] Sekiya I et al. Dexamethasone enhances SOX9 expression in chondrocytes. J. Endocrinol., 2001, 169: 573-579

[111] Park JS, Yang HN, Woo DG, Jeon SY, Park KH. SOX9 gene plus heparinized TGF-beta 3 coated dexamethasone loaded PLGA microspheres for inducement of chondrogenesis of hMSCs. Biomaterials, 2012, 33: 7151-7163

[112] Knudson CB, Knudson W. Cartilage proteoglycans. Semin. Cell Dev. Biol., 2001, 12: 69-78

[113] DeLise AM, Fischer L, Tuan RS. Cellular interactions and signaling in cartilage development. Osteoarthr. Cartil., 2000, 8: 309-334

[114] Jin EJ, Lee SY, Jung JC, Bang OS, Kang SS. TGF-beta3 inhibits chondrogenesis of cultured chick leg bud mesenchymal cells via downregulation of connexin 43 and integrin beta4. J. Cell. Physiol., 2008, 214: 345-353

[115] Jin EJ et al. Wnt-5a is involved in TGF-beta3-stimulated chondrogenic differentiation of chick wing bud mesenchymal cells. Int. J. Biochem. Cell Biol., 2006, 38: 183-195

[116] Mueller MB et al. Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs, 2010, 192: 158-166

[117] Pittenger MF et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284: 143-147

[118] Mehlhorn AT et al. Mesenchymal stem cells maintain TGF-beta-mediated chondrogenic phenotype in alginate bead culture. Tissue Eng., 2006, 12: 1393-1403

[119] Sekiya I, Colter DC, Prockop DJ. BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. Biochem. Biophys. Res. Commun., 2001, 284: 411-418

[120] Sasaki H et al. In vitro repair of meniscal radial tear with hydrogels seeded with adipose stem cells and TGF-beta3. Am. J. Sports Med., 2018, 46: 2402-2413

[121] Haider M, Cappello J, Ghandehari H, Leong KW. In vitro chondrogenesis of mesenchymal stem cells in recombinant silk-elastinlike hydrogels. Pharm. Res., 2008, 25: 692-699

[122] Chung C, Burdick JA. Influence of three-dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis. Tissue Eng. Part A, 2009, 15: 243-254

[123] Beier F. Cell-cycle control and the cartilage growth plate. J. Cell. Physiol., 2005, 202: 1-8

[124] Li B, Guan G, Mei L, Jiao K, Li H. Pathological mechanism of chondrocytes and the surrounding environment during osteoarthritis of temporomandibular joint. J. Cell. Mol. Med., 2021, 25: 4902-4911

[125] Hattori T et al. SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. Development, 2010, 137: 901-911

[126] Bohme K, Winterhalter KH, Bruckner P. Terminal differentiation of chondrocytes in culture is a spontaneous process and is arrested by transforming growth factor-beta 2 and basic fibroblast growth factor in synergy. Exp. Cell Res., 1995, 216: 191-198

[127] Moldovan F, Pelletier JP, Hambor J, Cloutier JM, Martel-Pelletier J. Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta. Arthritis Rheum., 1997, 40: 1653-1661

[128] Wilson SE. Interleukin-1 and transforming growth factor beta: commonly opposing, but sometimes supporting, master regulators of the corneal wound healing response to injury. Invest. Ophthalmol. Vis. Sci., 2021, 62: 8

[129] Hennig T et al. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J. Cell. Physiol., 2007, 211: 682-691

[130] Yang X et al. TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell Biol., 2001, 153: 35-46

[131] Blaney Davidson EN et al. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J. Immunol., 2009, 182: 7937-7945

[132] Komori T. Cell death in chondrocytes, osteoblasts, and osteocytes. Int. J. Mol. Sci., 2016, 17: 2045

[133] Zhang D et al. Osteoporosis-decreased extracellular matrix stiffness impairs connexin 43-mediated gap junction intercellular communication in osteocytes. Acta Biochim. Biophys. Sin. (Shanghai)., 2020, 52: 517-526

[134] Roach HI, Aigner T, Kouri JB. Chondroptosis: a variant of apoptotic cell death in chondrocytes? Apoptosis, 2004, 9: 265-277

[135] Green DR. The coming decade of cell death research: five riddles. Cell, 2019, 177: 1094-1107

[136] Elmore S. Apoptosis: a review of programmed cell death. Toxicol. Pathol., 2007, 35: 495-516

[137] Mrugala D et al. Gene expression profile of multipotent mesenchymal stromal cells: Identification of pathways common to TGFbeta3/BMP2-induced chondrogenesis. Cloning Stem Cells, 2009, 11: 61-76

[138] Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ., 2001, 8: 569-581

[139] Reggiori F, Klionsky DJ. Autophagy in the eukaryotic cell. Eukaryot. Cell, 2002, 1: 11-21

[140] Lockshin RA, Zakeri Z. Caspase-independent cell deaths. Curr. Opin. Cell Biol., 2002, 14: 727-733

[141] Ogier-Denis E, Codogno P. Autophagy: a barrier or an adaptive response to cancer. Biochim. Biophys. Acta, 2003, 1603: 113-128

[142] Garcia-Martinez V et al. Internucleosomal DNA fragmentation and programmed cell death (apoptosis) in the interdigital tissue of the embryonic chick leg bud. J. Cell Sci., 1993, 106: 201-208

[143] Dunker N, Schmitt K, Krieglstein K. TGF-beta is required for programmed cell death in interdigital webs of the developing mouse limb. Mech. Dev., 2002, 113: 111-120

[144] Cheah FS, Winkler C, Jabs EW, Chong SS. Tgfbeta3 regulation of chondrogenesis and osteogenesis in zebrafish is mediated through formation and survival of a subpopulation of the cranial neural crest. Mech. Dev., 2010, 127: 329-344

[145] Chen H, Cui Y, Zhang D, Xie J, Zhou X. The role of fibroblast growth factor 8 in cartilage development and disease. J. Cell Mol. Med., 2022, 26: 990-999

[146] Wu Q et al. Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice. Arthritis Rheum., 2008, 58: 3132-3144

[147] Hawker GA, Mian S, Bednis K, Stanaitis I. Osteoarthritis year 2010 in review: non-pharmacologic therapy. Osteoarthr. Cartil., 2011, 19: 366-374

[148] Funck-Brentano T, Cohen-Solal M. Crosstalk between cartilage and bone: when bone cytokines matter. Cytokine Growth Factor Rev., 2011, 22: 91-97

[149] Rogers J, Shepstone L, Dieppe P. Is osteoarthritis a systemic disorder of bone? Arthritis Rheum., 2004, 50: 452-457

[150] Suri S, Walsh DA. Osteochondral alterations in osteoarthritis. Bone, 2012, 51: 204-211

[151] Xie J et al. The effects of interleukin-1β in modulating osteoclast-conditioned medium’s influence on gelatinases in chondrocytes through mitogen-activated protein kinases. Int. J. Oral. Sci., 2015, 7: 220-231

[152] Kan S, Duan M, Liu Y, Wang C, Xie J. Role of mitochondria in physiology of chondrocytes and diseases of osteoarthritis and rheumatoid arthritis. Cartilage, 2021, 13: 1102S-1121S

[153] Aigner T, Gluckert K, von der Mark K. Activation of fibrillar collagen synthesis and phenotypic modulation of chondrocytes in early human osteoarthritic cartilage lesions. Osteoarthr. Cartil., 1997, 5: 183-189

[154] Goldring MB, Otero M. Inflammation in osteoarthritis. Curr. Opin. Rheumatol., 2011, 23: 471-478

[155] Kapetanakis, S. et al. Serum TGF-beta2 and TGF-beta3 are increased and positively correlated to pain, functionality, and radiographic staging in osteoarthritis. Orthopedics 33, https://doi.org/10.3928/01477447-20100625-09 (2010).

[156] Finnson KW, Parker WL, ten Dijke P, Thorikay M, Philip A. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes. J. Bone Miner. Res., 2008, 23: 896-906

[157] Remst DF et al. TGF-ss induces Lysyl hydroxylase 2b in human synovial osteoarthritic fibroblasts through ALK5 signaling. Cell Tissue Res., 2014, 355: 163-171

[158] Wang H. Effect of Sox9 on TGF-β1-mediated atrial fibrosis. Acta Biochim. Biophys. Sin. (Shanghai)., 2021, 53: 1450-1458

[159] Sueyoshi T, Yamamoto K, Akiyama H. Conditional deletion of Tgfbr2 in hypertrophic chondrocytes delays terminal chondrocyte differentiation. Matrix Biol., 2012, 31: 352-359

[160] Wang X et al. Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthr. Cartil., 2004, 12: 963-973

[161] Bauge C et al. Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes. Arthritis Rheum., 2007, 56: 3020-3032

[162] Mobasheri A, Kalamegam G, Musumeci G, Batt ME. Chondrocyte and mesenchymal stem cell-based therapies for cartilage repair in osteoarthritis and related orthopaedic conditions. Maturitas, 2014, 78: 188-198

[163] Hwang HS, Kim HA. Chondrocyte apoptosis in the pathogenesis of osteoarthritis. Int. J. Mol. Sci., 2015, 16: 26035-26054

[164] Zamli Z, Sharif M. Chondrocyte apoptosis: a cause or consequence of osteoarthritis? Int. J. Rheum. Dis., 2011, 14: 159-166

[165] Zhong G et al. miRNA-335-5p relieves chondrocyte inflammation by activating autophagy in osteoarthritis. Life Sci., 2019, 226: 164-172

[166] Dhollander AA et al. The use of scaffolds in the treatment of osteochondral lesions in the knee: current concepts and future trends. J. Knee Surg., 2012, 25: 179-186

[167] Xiang Y, Bunpetch V, Zhou W, Ouyang H. Optimization strategies for ACI: A step-chronicle review. J. Orthop. Transl., 2019, 17: 3-14

[168] Ahmed TA, Hincke MT. Mesenchymal stem cell-based tissue engineering strategies for repair of articular cartilage. Histol. Histopathol., 2014, 29: 669-689

[169] Crecente-Campo J, Borrajo E, Vidal A, Garcia-Fuentes M. New scaffolds encapsulating TGF-beta3/BMP-7 combinations driving strong chondrogenic differentiation. Eur. J. Pharm. Biopharm., 2017, 114: 69-78

[170] Yang Q et al. Silk fibroin/cartilage extracellular matrix scaffolds with sequential delivery of TGF-beta3 for chondrogenic differentiation of adipose-derived stem cells. Int. J. Nanomed., 2017, 12: 6721-6733

[171] Kim SH, Kim SH, Jung Y. TGF-beta3 encapsulated PLCL scaffold by a supercritical CO2-HFIP co-solvent system for cartilage tissue engineering. J. Control. Release, 2015, 206: 101-107

[172] Tang QO et al. Preclinical and clinical data for the use of mesenchymal stem cells in articular cartilage tissue engineering. Expert Opin. Biol. Ther., 2012, 12: 1361-1382

[173] Mrugala D et al. Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model. Ann. Rheum. Dis., 2008, 67: 288-295

[174] Wei W, Dai H. Articular cartilage and osteochondral tissue engineering techniques: recent advances and challenges. Bioact. Mater., 2021, 6: 4830-4855

[175] Cancedda R, Dozin B, Giannoni P, Quarto R. Tissue engineering and cell therapy of cartilage and bone. Matrix Biol., 2003, 22: 81-91

[176] Fan H et al. TGF-beta3 immobilized PLGA-gelatin/chondroitin sulfate/hyaluronic acid hybrid scaffold for cartilage regeneration. J. Biomed. Mater. Res. A, 2010, 95: 982-992

[177] Altman GH et al. Silk-based biomaterials. Biomaterials, 2003, 24: 401-416

[178] Wang Y, Kim UJ, Blasioli DJ, Kim HJ, Kaplan DL. In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials, 2005, 26: 7082-7094

[179] Zhou, C. et al. Hydrogel platform with tunable stiffness based on magnetic nanoparticles cross-linked GelMA for cartilage regeneration and its intrinsic biomechanism. Bioact. Mater. https://doi.org/10.1016/j.bioactmat.2022.07.013.

[180] Huang X, Zhong L, Post JN, Karperien M. Co-treatment of TGF-beta3 and BMP7 is superior in stimulating chondrocyte redifferentiation in both hypoxia and normoxia compared to single treatments. Sci. Rep., 2018, 8

[181] Luo Z et al. Mechano growth factor (MGF) and transforming growth factor (TGF)-beta3 functionalized silk scaffolds enhance articular hyaline cartilage regeneration in rabbit model. Biomaterials, 2015, 52: 463-475

[182] Yang Y et al. Transforming growth factor-β1-induced N-cadherin drives cell-cell communication through connexin43 in osteoblast lineage. Int. J. Oral. Sci., 2021, 13: 15

[183] Diekman BO, Rowland CR, Lennon DP, Caplan AI, Guilak F. Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix. Tissue Eng. Part A, 2010, 16: 523-533

[184] Ye K et al. Chondrogenesis of infrapatellar fat pad derived adipose stem cells in 3D printed chitosan scaffold. PLoS One, 2014, 9: e99410

[185] Choi S, Cho TJ, Kwon SK, Lee G, Cho J. Chondrogenesis of periodontal ligament stem cells by transforming growth factor-beta3 and bone morphogenetic protein-6 in a normal healthy impacted third molar. Int. J. Oral. Sci., 2013, 5: 7-13

[186] Ude CC et al. The evaluation of cartilage differentiations using transforming growth factor beta3 alone and with combination of bone morphogenetic protein-6 on adult stem cells. Cell Tissue Bank, 2017, 18: 355-367

[187] Hildner F et al. FGF-2 abolishes the chondrogenic effect of combined BMP-6 and TGF-beta in human adipose derived stem cells. J. Biomed. Mater. Res. A, 2010, 94: 978-987

[188] Park JS et al. Heparin-bound transforming growth factor-beta3 enhances neocartilage formation by rabbit mesenchymal stem cells. Transplantation, 2008, 85: 589-596

[189] Na K et al. Synergistic effect of TGFbeta-3 on chondrogenic differentiation of rabbit chondrocytes in thermo-reversible hydrogel constructs blended with hyaluronic acid by in vivo test. J. Biotechnol., 2007, 128: 412-422

[190] Lima EG et al. The beneficial effect of delayed compressive loading on tissue-engineered cartilage constructs cultured with TGF-beta3. Osteoarthr. Cartil., 2007, 15: 1025-1033

[191] Zhou C et al. Microenvironmental stiffness mediates cytoskeleton re-organization in chondrocytes through laminin-FAK mechanotransduction. Int. J. Oral. Sci., 2022, 14: 15

[192] Allen JL, Cooke ME, Alliston T. ECM stiffness primes the TGFbeta pathway to promote chondrocyte differentiation. Mol. Biol. Cell, 2012, 23: 3731-3742

[193] Song J et al. MicroRNA-488 regulates zinc transporter SLC39A8/ZIP8 during pathogenesis of osteoarthritis. J. Biomed. Sci., 2013, 20: 31

[194] Song J et al. MicroRNA-181b regulates articular chondrocytes differentiation and cartilage integrity. Biochem. Biophys. Res. Commun., 2013, 431: 210-214

[195] Yang B et al. MicroRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9. PLoS One, 2011, 6: e21679

[196] Sun B et al. A 3D-Bioprinted dual growth factor-releasing intervertebral disc scaffold induces nucleus pulposus and annulus fibrosus reconstruction. Bioact. Mater., 2021, 6: 179-190

[197] Martin AR et al. Nanofibrous hyaluronic acid scaffolds delivering TGF-beta3 and SDF-1alpha for articular cartilage repair in a large animal model. Acta Biomater., 2021, 126: 170-182

[198] Legemate K, Tarafder S, Jun Y, Lee CH. Engineering human TMJ discs with protein-releasing 3D-printed scaffolds. J. Dent. Res., 2016, 95: 800-807

[199] Merlin Rajesh Lal LP, Suraishkumar GK, Nair PD. Chitosan-agarose scaffolds supports chondrogenesis of Human Wharton’s Jelly mesenchymal stem cells. J. Biomed. Mater. Res. A, 2017, 105: 1845-1855

Funding

National Natural Science Foundation of China (National Science Foundation of China)(81771047)